Latest Breaking News On - Venture fund xlp atlas - Page 5 : comparemela.com

Disc Medicine (NASDAQ:IRON) Shares Gap Down to $62 26

Disc Medicine (NASDAQ:IRON) Shares Gap Down to $62 26
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Raymond jamesKevin bittermanDisc medicine incCantor fitzgeraldCitadel advisorsPolar capital holdings plcBlackrock incPerceptive advisorsVenture fund xlp atlasSecurities exchange commissionMorgan stanleyDisc medicineGet free reportDirector kevin bittermanVenture fundExchange commission

Disc Medicine (NASDAQ:IRON) Earns Buy Rating from HC Wainwright

Disc Medicine (NASDAQ:IRON) Earns Buy Rating from HC Wainwright
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Kevin bittermanDisc medicine company profileCitadel advisorsPerceptive advisorsVanguard group incVenture fund xlp atlasDisc medicine incFrazier life sciences managementCantor fitzgeraldMorgan stanleyDisc medicineFree reportMedicine trading downGet free reportDirector kevin bittermanVenture fund

Disc Medicine (NASDAQ:IRON) Rating Reiterated by Wedbush

Disc Medicine (NASDAQ:IRON) Rating Reiterated by Wedbush
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Kevin bittermanSecurities exchange commissionFrazier life sciences managementPerceptive advisorsDisc medicine incMorgan stanleyVenture fund xlp atlasVanguard group incCitadel advisorsCantor fitzgeraldDisc medicineFree reportMedicine trading downDirector kevin bittermanVenture fundExchange commission

Equities Analysts Set Expectations for Disc Medicine, Inc s Q1 2024 Earnings (NASDAQ:IRON)

Disc Medicine, Inc. (NASDAQ:IRON – Free Report) – Investment analysts at Leerink Partnrs reduced their Q1 2024 EPS estimates for shares of Disc Medicine in a note issued to investors on Thursday, March 21st. Leerink Partnrs analyst T. Smith now anticipates that the company will earn ($1.10) per share for the quarter, down from their […]

New zealand generalNew zealandKevin bittermanLeerink partnrsVenture fund xlp atlasVanguard group incCantor fitzgeraldWellington management groupVirtu financialMorgan stanleyGoldman sachs group incFinancial services group incSecurities exchange commissionDisc medicine incDisc medicine company profileDisc medicine

Disc Medicine (NASDAQ:IRON) Given New $80 00 Price Target at BMO Capital Markets

Disc Medicine (NASDAQ:IRON) Given New $80 00 Price Target at BMO Capital Markets
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Joanne bryceDisc medicine incSteward partners investment advisoryVenture fund xlp atlasSecurities exchange commissionCantor fitzgeraldTower research capitalAmeritas investment partners incMorgan stanleyDisc medicineGet free reportExchange commissionVenture fundPartners investment advisoryInvestment partnersResearch capital